O. Decaux

Evolution of the Cancer Stem Cell Model

Cryoglobulinemia Vasculitis

The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetase syndrome

A review on the association between inflammatory myopathies and vaccination

Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future

Therapy for Hepatitis C Virus–Related Cryoglobulinemic Vasculitis

Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study

SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution

Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma

Systemic sclerosis: a prototypic multisystem fibrotic disorder

Cold Hard Facts of Cryoglobulinemia

Raynaud phenomenon and the vascular disease in scleroderma

Renal cell carcinoma

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Treatment for hepatitis C virus-associated mixed cryoglobulinaemia

Inflammatory Muscle Diseases

Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy

Clinical trials in antineutrophil cytoplasmic antibody-associated vasculitis: what we have learnt so far, and what we still have to learn

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome

Interventions for renal vasculitis in adults

Treatment of hepatitis C virus–associated mixed cryoglobulinemia with direct‐acting antiviral agents

EASL Recommendations on Treatment of Hepatitis C 2018

Minor clone provides a reservoir for relapse in multiple myeloma

Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome

Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24

Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients

Exploration de la microcirculation pulpaire par écho-doppler digital chez des patients présentant une maladie de Raynaud ou une sclérodermie

Using Rituximab Plus Fludarabine and Cyclophosphamide as a Treatment for Refractory Mixed Cryoglobulinemia Associated With Lymphoma

Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. A prospective study in 117 patients

Rituximab versus azathioprine for maintenance in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (MAINRITSAN): Follow-up at 34 months

OP0213 Rituximab Versus Azathioprine for Maintenance in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis (MAINRITSAN): Follow Up at 34 Months